The Emerging Role of Vitamin C as a Treatment for Sepsis.

Markos G Kashiouris, Michael L'Heureux, Casey A Cable, Bernard J Fisher, Stefan W Leichtle, Alpha A Fowler
Author Information
  1. Markos G Kashiouris: Department of Internal Medicine, Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University School of Medicine, 1200 E Broad St., P.O. Box 980050, Richmond, VA 23298, Canada.
  2. Michael L'Heureux: Department of Internal Medicine, Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University School of Medicine, 1200 E Broad St., P.O. Box 980050, Richmond, VA 23298, Canada.
  3. Casey A Cable: Department of Internal Medicine, Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University School of Medicine, 1200 E Broad St., P.O. Box 980050, Richmond, VA 23298, Canada.
  4. Bernard J Fisher: Department of Internal Medicine, Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University School of Medicine, 1200 E Broad St., P.O. Box 980050, Richmond, VA 23298, Canada.
  5. Stefan W Leichtle: Department of Surgery, Division of Acute Care Surgical Services, Virginia Commonwealth University School of Medicine, 1200 E Broad St., P.O. Box 980454, Richmond, VA 23298, Canada.
  6. Alpha A Fowler: Department of Internal Medicine, Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University School of Medicine, 1200 E Broad St., P.O. Box 980050, Richmond, VA 23298, Canada.

Abstract

Sepsis, a life-threatening organ dysfunction due to a dysregulated host response to infection, is a leading cause of morbidity and mortality worldwide. Decades of research have failed to identify any specific therapeutic targets outside of antibiotics, infectious source elimination, and supportive care. More recently, vitamin C has emerged as a potential therapeutic agent to treat sepsis. Vitamin C has been shown to be deficient in septic patients and the administration of high dose intravenous as opposed to oral vitamin C leads to markedly improved and elevated serum levels. Its physiologic role in sepsis includes attenuating oxidative stress and inflammation, improving vasopressor synthesis, enhancing immune cell function, improving endovascular function, and epigenetic immunologic modifications. Multiple clinical trials have demonstrated the safety of vitamin C and two recent studies have shown promising data on mortality improvement. Currently, larger randomized controlled studies are underway to validate these findings. With further study, vitamin C may become standard of care for the treatment of sepsis, but given its safety profile, current treatment can be justified with compassionate use.

Keywords

References

  1. Am J Clin Nutr. 1991 Dec;54(6 Suppl):1153S-1156S [PMID: 1962563]
  2. Shock. 2017 Feb;47(2):132-139 [PMID: 27617671]
  3. Ann Am Thorac Soc. 2015 Feb;12(2):216-20 [PMID: 25569845]
  4. FEBS Lett. 1999 Nov 5;460(3):480-4 [PMID: 10556521]
  5. APMIS. 2017 May;125(5):468-475 [PMID: 28256016]
  6. Crit Care. 2018 Oct 11;22(1):258 [PMID: 30305111]
  7. J Nutr. 1991 Jan;121(1):126-30 [PMID: 1992049]
  8. PLoS Med. 2013 Dec;10(12):e1001577; discussion e1001577 [PMID: 24391478]
  9. Planta Med. 2012 Nov;78(17):1824-30 [PMID: 23059632]
  10. J Biol Chem. 2013 Mar 29;288(13):9092-101 [PMID: 23396969]
  11. Transplant Proc. 2009 Dec;41(10):4110-3 [PMID: 20005350]
  12. J Vasc Res. 2004 Jul-Aug;41(4):345-51 [PMID: 15340249]
  13. Crit Care. 2018 Dec 27;22(1):358 [PMID: 30587204]
  14. PLoS One. 2014 Nov 13;9(11):e111755 [PMID: 25392950]
  15. JAMA Netw Open. 2019 Feb 1;2(2):e187571 [PMID: 30768188]
  16. Int J Vitam Nutr Res. 1988;58(3):326-34 [PMID: 2461911]
  17. Chest. 2010 Sep;138(3):559-67 [PMID: 20507948]
  18. Crit Care. 2015 Nov 27;19:418 [PMID: 26612352]
  19. Br J Cancer. 1995 Nov;72(5):1173-9 [PMID: 7577464]
  20. Acta Cardiol. 2008 Jun;63(3):341-6 [PMID: 18664025]
  21. Nature. 2017 Sep 28;549(7673):476-481 [PMID: 28825709]
  22. Am J Physiol Lung Cell Mol Physiol. 2012 Jul 1;303(1):L20-32 [PMID: 22523283]
  23. Cent Eur J Immunol. 2014;39(1):116-21 [PMID: 26155111]
  24. Ann N Y Acad Sci. 1985;460:187-201 [PMID: 3008623]
  25. Genetica. 2011 Feb;139(2):199-207 [PMID: 21140195]
  26. JAMA. 2016 Feb 23;315(8):801-10 [PMID: 26903338]
  27. Crit Care Med. 2011 Jun;39(6):1454-60 [PMID: 21358394]
  28. JAMA. 2014 Apr 2;311(13):1308-16 [PMID: 24638143]
  29. Mediators Inflamm. 2014;2014:426740 [PMID: 25253919]
  30. J Clin Invest. 2016 May 2;126(5):1612-20 [PMID: 27135878]
  31. World J Crit Care Med. 2017 Feb 4;6(1):37-47 [PMID: 28224106]
  32. Nutr Clin Pract. 2016 Aug;31(4):457-74 [PMID: 27312081]
  33. J Surg Res. 2009 May 15;153(2):224-30 [PMID: 18952228]
  34. Nature. 1999 May 6;399(6731):70-5 [PMID: 10331392]
  35. Ann Intern Med. 2004 Apr 6;140(7):533-7 [PMID: 15068981]
  36. Subcell Biochem. 1996;25:109-15 [PMID: 8821971]
  37. Blood. 2011 May 19;117(20):5485-93 [PMID: 21346252]
  38. Am J Clin Nutr. 1971 Apr;24(4):432-43 [PMID: 5090631]
  39. Ann N Y Acad Sci. 1998 Nov 20;854:328-35 [PMID: 9928441]
  40. Infect Control Hosp Epidemiol. 2008 Jul;29(7):630-4 [PMID: 18564905]
  41. PLoS One. 2012;7(2):e32366 [PMID: 22389696]
  42. J Leukoc Biol. 2014 Dec;96(6):1165-75 [PMID: 25157026]
  43. Ann Surg. 2002 Dec;236(6):814-22 [PMID: 12454520]
  44. J Biol Chem. 1993 Jul 25;268(21):15531-5 [PMID: 8340380]
  45. Nutrients. 2013 Aug 09;5(8):3131-51 [PMID: 23939536]
  46. J Res Pharm Pract. 2016 Apr-Jun;5(2):94-100 [PMID: 27162802]
  47. Intensive Care Med. 2000;26 Suppl 1:S75-83 [PMID: 10786962]
  48. J Burn Care Res. 2015 Jan-Feb;36(1):50-6 [PMID: 25127026]
  49. J Surg Res. 2003 Feb;109(2):144-8 [PMID: 12643856]
  50. N Engl J Med. 2014 Jun 5;370(23):2191-200 [PMID: 24835849]
  51. Am J Clin Nutr. 1996 May;63(5):760-5 [PMID: 8615361]
  52. Shock. 2008 Dec;30(6):623-7 [PMID: 18497712]
  53. Free Radic Biol Med. 2005 Jun 15;38(12):1662-6 [PMID: 15917194]
  54. Nutrients. 2017 Nov 03;9(11): [PMID: 29099763]
  55. Chest. 2017 Jun;151(6):1229-1238 [PMID: 27940189]
  56. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3704-9 [PMID: 8623000]
  57. Chest. 2017 Jun;151(6):1199-1200 [PMID: 28599924]
  58. Int J Biochem Cell Biol. 2015 Oct;67:148-57 [PMID: 26193001]
  59. Br J Dermatol. 1980 Jan;102(1):49-56 [PMID: 7378281]
  60. Crit Care. 2018 Jul 13;22(1):176 [PMID: 30005596]
  61. Biochim Biophys Acta. 1981 Jan 7;672(1):123-7 [PMID: 6783120]
  62. Science. 2004 Mar 5;303(5663):1532-5 [PMID: 15001782]
  63. Mediators Inflamm. 2015;2015:614518 [PMID: 26273139]
  64. Front Immunol. 2018 Jan 04;8:1644 [PMID: 29354115]
  65. Histol Histopathol. 2014 Feb;29(2):177-89 [PMID: 24150912]
  66. Med Hypotheses. 2007;69(4):953-4 [PMID: 17376607]
  67. Blood. 2009 Oct 1;114(14):3033-43 [PMID: 19638625]
  68. Blood. 2007 Feb 1;109(3):1123-30 [PMID: 17008546]
  69. J Crit Care. 2016 Dec;36:125-129 [PMID: 27546760]
  70. N Engl J Med. 2012 May 31;366(22):2055-64 [PMID: 22616830]
  71. Stem Cell Res. 2013 Jan;10(1):36-47 [PMID: 23089627]
  72. Acta Anaesthesiol Scand. 2012 Mar;56(3):316-22 [PMID: 22150439]
  73. Antioxid Redox Signal. 2013 Dec 10;19(17):2068-83 [PMID: 23581713]
  74. Neuropsychopharmacology. 2013 Jan;38(1):23-38 [PMID: 22781841]
  75. Free Radic Biol Med. 2002 Nov 1;33(9):1173-85 [PMID: 12398925]
  76. N Engl J Med. 1991 Feb 14;324(7):429-36 [PMID: 1988827]
  77. Med Sci Monit. 2016 Jan 03;22:14-25 [PMID: 26724916]
  78. Lancet Infect Dis. 2015 May;15(5):581-614 [PMID: 25932591]
  79. Biofactors. 2009 Jan-Feb;35(1):5-13 [PMID: 19319840]
  80. Ann Intensive Care. 2017 Oct 6;7(1):102 [PMID: 28986821]
  81. J Surg Res. 2007 Sep;142(1):45-52 [PMID: 17559880]
  82. Science. 2001 Nov 9;294(5545):1337-40 [PMID: 11598268]
  83. Antioxid Redox Signal. 2017 May 1;26(13):718-742 [PMID: 27889956]
  84. Curr Top Membr. 2012;70:357-75 [PMID: 23177992]
  85. FEBS Lett. 2010 Jul 16;584(14):3193-7 [PMID: 20541553]
  86. Annu Rev Nutr. 2015;35:545-64 [PMID: 25974700]
  87. Antioxid Redox Signal. 2013 Dec 10;19(17):2129-40 [PMID: 23682970]
  88. Am J Clin Nutr. 1991 Dec;54(6 Suppl):1147S-1152S [PMID: 1962562]
  89. JCI Insight. 2018 Feb 8;3(3): [PMID: 29415887]
  90. Acta Biochim Pol. 2013;60(3):277-84 [PMID: 23819131]
  91. Adv Exp Med Biol. 1990;264:155-63 [PMID: 2244489]
  92. Chest. 2018 Jul;154(1):228-229 [PMID: 30044741]
  93. Br J Pharmacol. 2019 Jan;176(1):67-81 [PMID: 29931674]
  94. Am J Clin Nutr. 1991 Dec;54(6 Suppl):1214S-1220S [PMID: 1962573]
  95. Crit Rev Biochem Mol Biol. 2010 Apr;45(2):106-24 [PMID: 20199358]
  96. Chemotherapy. 1978;24(3):166-71 [PMID: 207492]
  97. Clin Exp Immunol. 1983 Jan;51(1):99-102 [PMID: 6339127]
  98. JAMA. 2019 Oct 1;322(13):1261-1270 [PMID: 31573637]
  99. J Crit Care. 2018 Oct;47:93-98 [PMID: 29936329]
  100. Sci Rep. 2016 Nov 16;6:37252 [PMID: 27849031]
  101. Front Cell Dev Biol. 2019 Jul 16;7:128 [PMID: 31380368]
  102. J Thromb Haemost. 2019 Nov;17(11):1827-1837 [PMID: 31322812]
  103. Nutrients. 2019 Jun 17;11(6): [PMID: 31212992]
  104. Oral Dis. 2016 Sep;22(6):463-93 [PMID: 26808119]
  105. Neuropharmacology. 2005 Mar;48(3):426-34 [PMID: 15721175]
  106. Am J Respir Crit Care Med. 2019 Oct 1;200(7):869-880 [PMID: 31162936]
  107. Intensive Care Med. 1999 Feb;25(2):180-5 [PMID: 10193545]
  108. Pharmacotherapy. 2018 Nov;38(11):1155-1161 [PMID: 30230568]
  109. Curr Opin Hematol. 2017 Jan;24(1):66-71 [PMID: 27820735]
  110. Curr Genomics. 2011 Aug;12(5):371-8 [PMID: 22294879]
  111. Crit Care. 2014 Aug 06;18(4):460 [PMID: 25185110]
  112. Arch Biochem Biophys. 1997 Jun 15;342(2):236-43 [PMID: 9186484]
  113. Intensive Care Med. 1996 Jul;22(7):707-10 [PMID: 8844239]
  114. Free Radic Biol Med. 1996;20(1):139-43 [PMID: 8903690]
  115. Adv Food Nutr Res. 2018;83:281-310 [PMID: 29477224]
  116. Mol Cell Biol. 2004 Aug;24(15):6645-52 [PMID: 15254232]
  117. Proc Natl Acad Sci U S A. 1970 Dec;67(4):1643-8 [PMID: 5275366]
  118. Crit Care. 2008;12(4):R101 [PMID: 18687132]
  119. J Am Coll Surg. 2018 Dec;227(6):587-595 [PMID: 30243993]
  120. J Immunol. 2012 Sep 15;189(6):2689-95 [PMID: 22956760]
  121. Biochem Biophys Res Commun. 2013 Jan 11;430(2):579-84 [PMID: 23228664]
  122. Antioxid Redox Signal. 2013 Dec 10;19(17):2054-67 [PMID: 23249337]
  123. Shock. 2017 Sep;48(3):340-345 [PMID: 28107214]
  124. Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72 [PMID: 26414292]
  125. J Transl Med. 2014 Jan 31;12:32 [PMID: 24484547]
  126. PLoS One. 2016 Feb 05;11(2):e0148142 [PMID: 26849138]
  127. Arch Surg. 2000 Mar;135(3):326-31 [PMID: 10722036]
  128. Am J Respir Crit Care Med. 2013 Apr 1;187(7):743-50 [PMID: 23348980]
  129. J Nutr. 1977 Aug;107(8):1507-12 [PMID: 328832]
  130. Crit Care Med. 1996 Mar;24(3):392-7 [PMID: 8625625]
  131. J Lipid Res. 1992 Mar;33(3):385-97 [PMID: 1314881]
  132. Mol Pharmacol. 2006 Nov;70(5):1469-80 [PMID: 16887934]

Grants

  1. UL1 TR002649/NCATS NIH HHS

MeSH Term

Administration, Intravenous
Ascorbic Acid
Humans
Sepsis
Vitamins

Chemicals

Vitamins
Ascorbic Acid

Word Cloud

Created with Highcharts 10.0.0CvitaminsepsisSepsismortalitytherapeuticcareVitaminshownsepticintravenousimprovingfunctionsafetystudiestreatmentlife-threateningorgandysfunctionduedysregulatedhostresponseinfectionleadingcausemorbidityworldwideDecadesresearchfailedidentifyspecifictargetsoutsideantibioticsinfectioussourceeliminationsupportiverecentlyemergedpotentialagenttreatdeficientpatientsadministrationhighdoseopposedoralleadsmarkedlyimprovedelevatedserumlevelsphysiologicroleincludesattenuatingoxidativestressinflammationvasopressorsynthesisenhancingimmunecellendovascularepigeneticimmunologicmodificationsMultipleclinicaltrialsdemonstratedtworecentpromisingdataimprovementCurrentlylargerrandomizedcontrolledunderwayvalidatefindingsstudymaybecomestandardgivenprofilecurrentcanjustifiedcompassionateuseEmergingRoleTreatmentHDIVChigh-doseshock

Similar Articles

Cited By